VivoSeq
Other

Oocyte

0

Pipeline Programs↗

1

Active Trials↗

0

Companies Involved↗

Oocyte is an early-stage landscape with 0 programs across 0 companies.

Intelligence

Pipeline Metrics

Competitive Density

6/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

83/100

Attrition Rate

10/100

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

21

clinical trials

Completed10 · 48%
Unknown status8 · 38%
Withdrawn2 · 10%
Recruiting1 · 5%

Clinical Trials

Trial Activity

21 trials

Usefulness of Corifollitropin α as Alternative to Conventional Daily rFSH Protocols in Oocyte Donors Undergoing Pituitary Suppression With Medroxiprogesterona Acetate (MPA)
Recruiting·IInstituto Valenciano de Infertilidad, IVI VALENCIA·N/A·NCT06193135·318 enrolled
Artificial Oocyte Activation Comparing Tow Different Agents
Completed·IIbn Sina Hospital·N/A·NCT02424214·450 enrolled
Cabergoline Before or After Oocyte Collection for Follicular Resolution
Completed·FFertility Center of Las Vegas·Phase 4·NCT04096027·70 enrolled
GnRH Agonist and Antagonists in an Oocyte Donation Program
Completed·IInstituto Valenciano de Infertilidad, IVI VALENCIA·Phase 4·NCT00505817
DYG Versus Cetrorelix in Oocyte Donation
Completed·CClinica de la Mujer Medicina Reproductiva, Chile·N/A·NCT05577806·202 enrolled
Higher Dose of Rekovelle in Oocyte Donors
Completed·IIVI Madrid·Phase 2·NCT04778358·40 enrolled
The Value of Addition of Human Menopausal Gonadotropin Drug Following Oocytes Retrieval in IVF Cycles
Completed·—·Phase 4·NCT03209687·600 enrolled
GnRHa Trigger in Asian Oocyte Donors- a Dose Finding Study
Completed·VVietnam National University·N/A·NCT02208986·165 enrolled
Use of Antagonist Versus Agonist GnRH in Oocyte Recipient Endometrium Preparation
Completed·IInstituto Valenciano de Infertilidad, IVI VALENCIA·Phase 4·NCT00633347·570 enrolled
Luteal Phase Supplementation With Recombinant LH After GnRh Agonist Oocytes Triggering in Women at Risk of OHSS
Completed·SSan Carlo Public Hospital, Potenza, Italy·N/A·NCT02200952·16 enrolled
Follicle Size and Oocyte Development
Completed·SSheba Medical Center·N/A·NCT03660813·200 enrolled
Fertilizations With Immotile Sperm: Pentoxyphylline Activation Alone, or With Chemical Oocyte Activation
Withdrawn·RRambam Health Care Campus·Phase 4·NCT02051075
In Vitro Maturation (IVM) of Human Oocytes
Withdrawn·NNorthwell Health·N/A·NCT01843569
Study on Influence of Leutinizing Hormone (LH) on Oocyte Maturity
Unknown status·SSouthern Cross Fertility Centre·N/A·NCT01595334·300 enrolled
Use of Corifolitropin Alfa in Oocyte Donors
Unknown status·IIVI Madrid·Phase 4·NCT02213627·300 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)